| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910851 | Lung Cancer | 2015 | 9 Pages |
Abstract
The present study is the first to show a relationship between the genetic variation rs8100239 of BCL3 and cancer patients' survival. It also represents the first quantitative evaluation of BCL3 expression in NSCLC. Our findings indicate that rs8100239 may be considered as a novel prognostic indicator, demonstrating also the overexpression of BCL3 protein in NSCLC and implicating this pivotal molecule in the pathogenesis of NSCLC.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Foteinos-Ioannis D. Dimitrakopoulos, Anna G. Antonacopoulou, Anastasia Kottorou, Stella Marousi, Ioulia Koukourikou, Melpomeni Kalofonou, Nikolaos Panagopoulos, Chrisoula Scopa, Dimitrios Dougenis, Helen Papadaki, Athanasios G. Papavassiliou,